Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadoquatrane Pharmacokinetics and Safety in Pediatric Participants Undergoing CE-MRI
NCT05915026Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of gadoquatrane, sponsored by Bayer. Started Aug 2023; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on NCT05915026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05915026.